These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 25771849)

  • 21. The interactive effects of test-retest and methylphenidate administration on cognitive performance in youth with ADHD: A double-blind placebo-controlled crossover study.
    Horowitz I; Avirame K; Naim-Feil J; Rubinson M; Moses E; Gothelf D; Levit-Binnun N
    Psychiatry Res; 2020 Sep; 291():113056. PubMed ID: 32554183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of methylphenidate and behavioral contingencies on sustained attention in attention-deficit hyperactivity disorder: a test of the reward dysfunction hypothesis.
    Solanto MV; Wender EH; Bartell SS
    J Child Adolesc Psychopharmacol; 1997; 7(2):123-36. PubMed ID: 9334897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methylphenidate-evoked changes in striatal dopamine correlate with inattention and impulsivity in adolescents with attention deficit hyperactivity disorder.
    Rosa-Neto P; Lou HC; Cumming P; Pryds O; Karrebaek H; Lunding J; Gjedde A
    Neuroimage; 2005 Apr; 25(3):868-76. PubMed ID: 15808987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-acting methylphenidate has an effect on aggressive behavior in children with attention-deficit/hyperactivity disorder.
    Sinzig J; Döpfner M; Lehmkuhl G; ; Uebel H; Schmeck K; Poustka F; Gerber WD; Günter M; Knölker U; Gehrke M; Hässler F; Resch F; Brünger M; Ose C; Fischer R
    J Child Adolesc Psychopharmacol; 2007 Aug; 17(4):421-32. PubMed ID: 17822338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder.
    Coghill D; Banaschewski T; Lecendreux M; Soutullo C; Johnson M; Zuddas A; Anderson C; Civil R; Higgins N; Lyne A; Squires L
    Eur Neuropsychopharmacol; 2013 Oct; 23(10):1208-18. PubMed ID: 23332456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive Testing to Identify Children With ADHD Who Do and Do Not Respond to Methylphenidate.
    Elliott GR; Blasey C; Rekshan W; Rush AJ; Palmer DM; Clarke S; Kohn M; Kaplan C; Gordon E
    J Atten Disord; 2017 Dec; 21(14):1151-1160. PubMed ID: 25122732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and therapeutic effect of OROS methylphenidate under different breakfast conditions in children with attention-deficit/hyperactivity disorder.
    Wigal SB; Gupta S; Heverin E; Starr HL
    J Child Adolesc Psychopharmacol; 2011 Jun; 21(3):255-63. PubMed ID: 21663428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Once-daily multilayer-release methylphenidate in a double-blind, crossover comparison to immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder.
    Weiss M; Hechtman L; Turgay A; Jain U; Quinn D; Ahmed TS; Yates T; Reiz JL; Donnelly GA; Harsanyi Z; Darke AC
    J Child Adolesc Psychopharmacol; 2007 Oct; 17(5):675-88. PubMed ID: 17979587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methylphenidate enhances cognitive performance in adults with poor baseline capacities regardless of attention-deficit/hyperactivity disorder diagnosis.
    Agay N; Yechiam E; Carmel Z; Levkovitz Y
    J Clin Psychopharmacol; 2014 Apr; 34(2):261-5. PubMed ID: 24525641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naïve children with ADHD during a rewarded continuous performance task.
    Rubia K; Halari R; Cubillo A; Mohammad AM; Brammer M; Taylor E
    Neuropharmacology; 2009 Dec; 57(7-8):640-52. PubMed ID: 19715709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methylphenidate effects in attention deficit/hyperactivity disorder: electrodermal and ERP measures during a continuous performance task.
    Lawrence CA; Barry RJ; Clarke AR; Johnstone SJ; McCarthy R; Selikowitz M; Broyd SJ
    Psychopharmacology (Berl); 2005 Nov; 183(1):81-91. PubMed ID: 16160877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Norepinephrine genes predict response time variability and methylphenidate-induced changes in neuropsychological function in attention deficit hyperactivity disorder.
    Kim BN; Kim JW; Cummins TD; Bellgrove MA; Hawi Z; Hong SB; Yang YH; Kim HJ; Shin MS; Cho SC; Kim JH; Son JW; Shin YM; Chung US; Han DH
    J Clin Psychopharmacol; 2013 Jun; 33(3):356-62. PubMed ID: 23609393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of a skipped dose (placebo) of methylphenidate on the learning and retention of a motor skill in adolescents with Attention Deficit Hyperactivity Disorder.
    Fox O; Adi-Japha E; Karni A
    Eur Neuropsychopharmacol; 2014 Mar; 24(3):391-6. PubMed ID: 24332892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The utility of a continuous performance test embedded in virtual reality in measuring the effectiveness of MPH treatment in boys with ADHD].
    Shriki L; Weizer M; Pollak Y; Weiss PL; Rizzo AA; Gross-Tsur V
    Harefuah; 2010 Jan; 149(1):18-23, 63. PubMed ID: 20422835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mediators of methylphenidate effects on math performance in children with attention-deficit hyperactivity disorder.
    Froehlich TE; Antonini TN; Brinkman WB; Langberg JM; Simon JO; Adams R; Fredstrom B; Narad ME; Kingery KM; Altaye M; Matheson H; Tamm L; Epstein JN
    J Dev Behav Pediatr; 2014; 35(2):100-7. PubMed ID: 24509055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma methylphenidate concentrations in youths treated with high-dose osmotic release oral system formulation.
    Stevens JR; George RA; Fusillo S; Stern TA; Wilens TE
    J Child Adolesc Psychopharmacol; 2010 Feb; 20(1):49-54. PubMed ID: 20166796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylphenidate, interstimulus interval, and reaction time performance of children with attention deficit/hyperactivity disorder: a pilot study.
    van der Meere JJ; Shalev RS; Borger N; Wiersema JR
    Child Neuropsychol; 2009 Nov; 15(6):554-66. PubMed ID: 19296298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose methylphenidate treatment of attention deficit hyperactivity disorder in a preschooler.
    Lipkin PH; Butz AM; Cozen MA
    J Child Adolesc Psychopharmacol; 2003; 13(1):103-6. PubMed ID: 12804131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dissociation in response to methylphenidate on response variability in a group of medication naïve children with ADHD.
    Johnson KA; Barry E; Bellgrove MA; Cox M; Kelly SP; Dáibhis A; Daly M; Keavey M; Watchorn A; Fitzgerald M; McNicholas F; Kirley A; Robertson IH; Gill M
    Neuropsychologia; 2008 Apr; 46(5):1532-41. PubMed ID: 18289615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of methylphenidate on multiple components of attention in children with attention deficit hyperactivity disorder.
    Tucha O; Prell S; Mecklinger L; Bormann-Kischkel C; Kübber S; Linder M; Walitza S; Lange KW
    Psychopharmacology (Berl); 2006 Apr; 185(3):315-26. PubMed ID: 16521033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.